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Received 18 August 2016; revised 2 September 2016; accepted 6 September 2016AbstractObjective: The present study aimed to evaluate the possibility of using coherent anti-Stokes Raman spectroscopy (CARS) microscopy to
determine the specific molecular morphology of cholesteatoma by detecting the natural vibrational contrast of the chemical bonds without any
staining.
Materials and methods: Specimens from the mastoid and tympanic membrane with and without cholesteatoma were analyzed using CARS
microscopy, two-photon excited fluorescence (TPEF) microscopy, and the second harmonic generation (SHG) microscopy.
Results: In cholesteatoma tissues from the mastoid, a strong resonant signal at 2845 cm1 was observed by CARS, which indicated the detection
of the CH2 hydro-carbon lipid bonds that do not generate visible signals at 2940 cm
1 suggestive of CH3 bonds in amino acids. A strong resonant
signal at 2940 cm1 appeared in an area of the same specimen, which also generated abundant signals by TPEF and SHG microscopy at 817 nm,
which was suggestive of collagen. In the tympanic membrane specimen with cholesteatoma, a strong resonant signal with corrugated
morphology was detected, which indicated the presence of lipids. A strong signal was detected in the tympanic membrane with chronic otitis
media using TPEF/SHG at 817 nm, which indicated collagen enrichment. The CARS and TPEF/SHG images were in accordance with the
histology results.
Conclusion: These results suggest the need to develop a novel CARS microendoscope that can be used in combination with TPEF/SHG to
distinguish cholesteatoma from inflammatory tissues.
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Cholesteatoma is a benign, gradually expanding destructive
cystic epithelial lesion of the temporal bone that is generated
from keratinizing stratified squamous epithelium (Semaan and
Megerian, 2006). Surgical removal of the pathological tissue is
the only effective therapy for cholesteatoma, but some cases of
cholesteatoma can recur after this procedure (Tomlin et al.,
2013; Neudert et al., 2014). Indeed, the rate of residualgy Head and Neck Surgery. Production and hosting by Elsevier (Singapore)
eativecommons.org/licenses/by-nc-nd/4.0/).
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and surgery is the major contribution to recurrence in the
clinic (Wilson et al., 2013). Even the application of endoscope
during surgery in combination with operating microscope only
provides an incremental benefit for prevention of residual
cholesteatoma (James et al., 2016). Our hypothesis is that the
conventional endoscope has a limitation in detecting focal
cholesteatoma due to its lower spatial resolution and poorer
depth sensation than the operating microscope. Therefore,
there is a need to improve the visualization by developing a
novel endoscopic approach that is capable of detecting the
specific chemical structures within the cholesteatoma to assure
a clear surgical margin during surgery. This potential novel
endoscope may also be useful to predict which retraction
pocket on the tympanic membrane will develop into choles-
teatoma and guide the treatment strategy in the clinic.
Raman spectroscopy is a powerful tool capable of gener-
ating a characteristic signature of the sample material and
operates by detecting energy associated with the molecular
bond vibrations. The process in which the incident photons
scatter inelastically upon interaction with matter is also known
as Raman scattering (Wachsmann-Hogiu et al., 2009). Pandey
et al. reported that Raman spectroscopy is capable of
discerning the molecular pathology of differential proliferative
middle ear lesions and may aid in the assessment of patho-
logical borders to improve surgical outcomes in cases of
middle ear disease (Pandey et al., 2015). However, the Raman
spectroscopy signal is faint and insufficient for clinical
application during surgery. High-resolution coherent anti-
Stokes Raman spectroscopy (CARS) is an advanced molecu-
lar imaging technique that has recently been applied to label-
free imaging of cells and tissues using the natural vibrational
contrast and has significantly boosted and enhanced Raman
signal levels (Pezacki et al., 2011; Moura et al., 2016). CARS
occurs when a target molecule is simultaneously irradiated by
two laser beams at different frequencies, a pump beam uP and
a Stokes beam uS. When the difference between the higher
frequency (pump beam) and the lower frequency (Stokes
beam) equals the vibrational frequency of the target bond of
the molecule, a CARS signal is generated (Pezacki et al.,
2011; Folick et al., 2011; Rodriguez et al., 2006).
We aimed to evaluate the feasibility of using CARS mi-
croscopy to display the specific molecular morphology of
cholesteatoma and the potential of CARS to be integrated as a
novel endoscope for cholesteatoma imaging in the clinic. We
focused on detecting the vibrations of CH2 bonds in the lipids
accumulated in the cholesteatoma and the CH3 bonds in the
peptides of proteins that are enriched in the tissues of chronic
suppurative otitis media attributed to the inflammatory in-
filtrations and biofilm formation, among others (Fig. 1)
(Bloksgaard et al., 2012; Gu et al., 2014; Knutsson et al.,
2011; Uno and Saito, 1995). Two-photon excited fluores-
cence (TPEF) and potentially the second harmonic generation
(SHG) from fibrillar collagen structures caused by chronic
inflammation was also evaluated (Knutsson et al., 2011; Uno
and Saito, 1995; Jiang et al., 2011).2. Materials and methods2.1. SpecimensThe following 4 types of specimens were collected from 3
patients undergoing middle ear surgeries at the Helsinki Uni-
versity Central Hospital: cholesteatoma tissues from the
mastoid, the mucosa of the temporal bone air cell without
visible cholesteatoma in the same mastoid that was 10 mm
away from the identified cholesteatoma, the tympanic mem-
brane with cholesteatoma on the mucosa layer, and the re-
sidual membrane near the perforation of the tympanic
membrane of chronic otitis media. After surgical removal, all
specimens were immediately fixed using 4% formaldehyde
overnight and maintained in phosphate-buffered saline (PBS,
0.01 M, pH 7.4) until CARS microscopy and histology study.
No additional procedures were added to the standard surgery
when the specimens were obtained, and no personal infor-
mation was exposed. The study protocol was approved by the
ethics committee of the Helsinki University Central Hospital
and followed the rules of the Declaration of Helsinki, which
was developed by the World Medical Association and was
updated at the 64th WMA General Assembly in Fortaleza,
Brazil, in 2013 (WMA Declaration of Helsinki e Ethical
Principles for Medical Research Involving Human Subjects,
2014).2.2. CARS microscopyThe images were acquired with a commercial Leica TCS
SP8 CARS confocal microscope (Leica Microsystems GmbH,
Wetzlar, Germany), which consists of an inverted microscope
equipped with an ultra-short pulsed light source (picoEmerald,
APE, Berlin, Germany) that produces the two synchronous
beams needed for CARS microscopy. The Stokes beam at
1064 nm was emitted from a neodymium-doped yttrium
orthovanadate (Nd:YVO4) laser while a tunable pump/probe
beam at 780e940 nm was generated by an optical parametric
oscillator (OPO). The pulse width was 5e7 ps with a repeti-
tion rate of 80 MHz corresponding to the Raman line width of
2e3 cm1. The pulses from the two sources were temporally
and spatially overlapped on the focal plane of the microscope.
Up to 100 mW of average power from both the pump and the
Stokes source was delivered to the specimen with an identical
laser intensity for each measurement. The laser generating
wavelength of 817 nm was used for the CARS modality
simultaneously with the Stokes beam at 1064 nm to excite the
symmetric vibrational resonance of the CH2 hydro-carbon
bonds in the lipids at 2845 cm1 and that of the CH3 bonds
in amino acids of the proteins at 2940 cm1 (Pirhonen et al.,
2016; Surmacki et al., 2013). Meanwhile, the TPEF and
SHG was measured using excitation at 817 nm and broad-band
detection at 380 nm e 550 nm according to the literature
(Jiang et al., 2011). The detected TPEF was compared with the
conventional autofluorescent microscopy measured with
488 nm excitation. The generated two-photon excited and
Fig. 1. Chemical structures of a saturated fatty acid and peptide. There are plenty of CH2 bonds in the saturated fatty acid (A) and CH3 bonds in the peptide (B).
129J. Zou et al. / Journal of Otology 11 (2016) 127e133CARS signals were detected in the epi-direction using a non-
descanned photomultiplier tube (PMT) detector.
The images were acquired from formaldehyde-fixed tissues
using a 25 water immersion objective (Leica HCX IR APO
L 25/0.95 W). All images were recorded using the Leica
Application Suite X (LAS X) software (Leica Microsystems
GmbH, Wetzlar, Germany).2.3. Histological studyAfter CARS microscopy, the specimens were embedded in
paraffin and sectioned at 4 mm thickness using a standardFig. 2. Comparison of label-free CARS microscopy and SHG/TPEF of cholestea
resonant signals at 2845 cm1 and 2940 cm1 and a SHG/TPEF signal at 817 nm
(AeC). Weak resonant signals at 2845 cm1 and a SHG/TPEF signal in the mucos
collagen; Lip: lipid; Pro: protein. Scale bar ¼ 25 mm (AeC) and 50 mm (D, E).protocol. The sections were processed for hematoxylin-eosin
(H & E) staining after deparaffinization by following a stan-
dard protocol. The slices were observed under a light micro-
scope (Leica DM2000 microscope) equipped with an Olympus
DP25 camera (Olympus Corporation, Tokyo, Japan).
3. Results3.1. CARS microscopyIn the cholesteatoma tissue collected from the mastoid, a
strong resonant signal occurred at 2845 cm1 indicatingtoma tissue and mucosa of the temporal bone air cell in the mastoid. Strong
excitation were detected in the cholesteatoma tissue (Ch) in different areas
a (Mu) of the temporal bone air cell in the mastoid were observed (D, E). Col:
Fig. 3. Comparison of label-free CARS microscopy of the tympanic membrane with cholesteatoma on the mucosa layer and the residual membrane near the
perforation of the tympanic membrane in chronic otitis media (COM). The tympanic membrane with cholesteatoma (Ch) displayed a strong resonant signal at
2845 cm1 but only weak autofluorescence and no SHG excited by the 817 nm laser (A, B). The tympanic membrane of COM did not produce a resonant signal at
2845 cm1 but did exhibit a strong SHG/TPEF signal (C, D). Col: collagen; Lip: lipid. Scale bar ¼ 25 mm.
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displayed corrugated morphology with occasional bright
spots. These structures did not generate visible signals at
2940 cm1, which is thought to excite the CH3 bonds in the
amino acids of proteins. However, a strong resonant signal at
2940 cm1 appeared in an area of the same specimen, which
generated abundant SHG signals excited at 817 nm, sugges-
tive of collagen. A weak signal was detected in the lipid area
of the cholesteatoma tissue and the mucosa of the temporal
bone air cell in the same mastoid using 817 nm excitation
(Fig. 2).
In the tympanic membrane with cholesteatoma on the
mucosa layer specimen, a strong resonant signal with corru-
gated morphology was detected at 2845 cm1, indicating the
presence of CH2 hydro-carbon bonds of the lipids. Excitation
at 817 nm did not lead to emission from the same specimen.
However, a strong SHG/TPEF signal was generated on the
residual membrane near the perforation of the tympanic
membrane of chronic otitis media using 817 nm excitation,
which indicated collagen enrichment. CARS microscopy
showed only a weak resonant signal at 2845 cm1, which was
expected to excite lipids (Fig. 3).The observed results were consistent in all analyzed spec-
imens without exception.3.2. HistologyH & E staining demonstrated the appearance of specific
lipids with obvious corrugated morphology in the specimens
of cholesteatoma tissue collected from the mastoid and tym-
panic membrane with cholesteatoma on the mucosa layer.
Extensive infiltration of inflammatory cells appeared in the
specimens of the mucosa of the temporal bone air cell in the
mastoid and the residual membrane near the perforation of the
tympanic membrane in chronic otitis media. Proliferations of
connective tissue and epithelial cells were demonstrated in the
specimen of residual membrane near the perforation of the
tympanic membrane in chronic otitis media (Fig. 4).
4. Discussions
The present study demonstrated that CARS microscopy
depicted specific images of cholesteatoma in the mastoid and
tympanic membrane by exciting the symmetric vibrational
Fig. 4. H.E. staining of cholesteatoma tissue and inflammatory tissue of the temporal bone air cell in the mastoid and tympanic membrane. Lipids with obvious
corrugated morphology appeared in the cholesteatoma tissues of the temporal bone air cell in the mastoid (ChMa) and tympanic membrane (ChTM) (A, B, E, and
F). Infiltration of inflammatory cells were detected in the mucosa of the temporal bone air cell in the mastoid (MuMa) and the residual membrane near the
perforation of the tympanic membrane in chronic otitis media (COMTM) (C, D, G, and H). There was obvious proliferation of connective tissue and epithelial cells
in the tympanic membrane of chronic otitis media (G, H). Epi: epithelial cells; Fib: collagen fibers; Inf: infiltration of inflammatory cells; Lip: lipids. Scale
bar ¼ 20 mm.
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2845 cm1 using a laser generating wavelength of 817 nm for
the CARS modality simultaneously with the Stokes beam at
1064 nm. Meanwhile, the enrichment of collagen in the
proliferated connective tissue of the residual tympanic mem-
brane of chronic otitis media and the cholesteatoma in the
mastoid was displayed using SHG/TPEF at 817 nm. The
CARS microscopic images and SHG/TPEF images were in
accordance with the histological results. The existence of
collagen fiber bundles in cholesteatoma tissues has been re-
ported, and these collagen fibers are composed of types I, II,
and IV (Knutsson et al., 2011). There has been no report
regarding collagen composition of the cholesteatoma in the
human tympanic membrane. However, there was a report on
the collagen structure of a healthy tympanic membrane during
healing of a perforation and during infection in an animal
model (Stenfeldt et al., 2006). In the animal model study, type
II collagen was the main constituent of the lamina propria of
the pars tensa. After myringotomy, collagen types I and III
were found at the perforation border and around the dilated
blood vessels early in the healing phase. During infection, the
collagen layer was thickened and stained strongly for type II
collagen. Collagen types I and III were found in the edematous
connective tissue around the main collagen layer and around
dilated blood vessels. Three months after perforation or
infection, all 3 collagens were present in the lamina propria of
the tympanic membrane (Stenfeldt et al., 2006).
These results provided evidence for the need to develop a
novel CARS microendoscope that can be used in combination
with a SHG/TPEF microscope to distinguish the choles-
teatoma from inflammatory tissues. The potential imaging
system may also help detect residuals on dural surfaces in
large petrous bone cholesteatoma and epidermoid lesions
during surgery. Diffusion weighted MRI (DWMRI) has been
reported to be able to differentiate recurrent cholesteatoma
from granulation tissue after mastoidectomy (Maheshwari and
Mukherji, 2002; De Foer et al., 2008). However, it impossible
to apply MRI during surgery. There is a limitation for DWMRI
to detect cholesteatoma in the tympanic membrane due to its
thin structure. The current laser systems are very expensive but
an affordable solution could potentially be developed in the
future. Some studies have reported the development of a
CARS endoscope, although the system needs further
improvement (Brustlein et al., 2011; Satira, 2013). It is
feasible to develop a hybrid microscopic system using CARS
and SHG/TPEF for clinical application in cholesteatoma.
In conclusion, the present study demonstrated that CARS
microscopy is capable of visualizing the cholesteatoma in the
mastoid and tympanic membrane by exciting the symmetric
vibrational resonance of the CH2 hydro-carbon bonds in the
lipids and distinguishing the inflammatory mucosa from the
tympanic membrane with perforation. The SHG/TPEF excited
at 817 nm is effective for visualizing the existence of collagen
bundles in inflammatory tissues. There is a potential to
develop CARS endoscope for in vivo detection of choles-
teatoma in patients.References
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